Cost of severe hypoglycaemia in nine European countries-Reference-Cited by-同舟云学术

Cost of severe hypoglycaemia in nine European countries

Published:2016-06-03 Issue:10 Volume:19 Page:973-982
ISSN:1369-6998
Container-title:Journal of Medical Economics
language:en
Short-container-title:Journal of Medical Economics

Author:

Jakubczyk Michał¹,Lipka Izabela²,Pawęska Justyna²,Niewada Maciej³,Rdzanek Elżbieta²,Zaletel Jelka⁴,Ramírez de Arellano Antonio⁵,Doležal Tomáš⁶⁷,Chekorova Mitreva Biljana⁸,Nagy Bence⁹,Petrova Guenka¹⁰,Šarić Tereza¹¹,Yfantopoulos John¹²,Czech Marcin¹³¹⁴

Affiliation:

1. Decision Analysis and Support Unit, Warsaw School of Economics, Poland;

2. HealthQuest spółka z ograniczoną odpowiedzialnością Sp. K, Warsaw, Poland;

3. Department of Experimental and Clinical Pharmacology, Medical University of Warsaw, Poland;

4. Department of Endocrinology, Diabetes and Metabolic Diseases, University Medical Centre, Ljubljana, Slovenia;

5. Novo Nordisk Pharma, Spain;

6. Institute of Health Economics and Technology Assessment, Prague, the Czech Republic;

7. Department of Pharmacology, 2nd Faculty of Medicine, Prague, the Czech Republic;

8. Novo Nordisk Pharma, Macedonia, the former Yugoslav Republic of Macedonia;

9. Healthware Consulting Ltd, Budapest, Hungary;

10. Department of Social Pharmacy and Pharmacoeconomics, Faculty of Pharmacy, Medical University of Sofia, Bulgaria;

11. Promeritus savjetovanje Ltd., Zagreb, Croatia;

12. School of Economics and Political Science, University of Athens, Greece;

13. Department of Pharmacoeconomics, Medical University of Warsaw, Poland;

14. Business School, Warsaw University of Technology, Poland

Funder

Novo Nordisk

Publisher

Informa UK Limited

Subject

Health Policy

Link

https://www.tandfonline.com/doi/pdf/10.1080/13696998.2016.1188823

Reference62 articles.

1. Estimating the current and future costs of Type 1 and Type 2 diabetes in the UK, including direct health costs and indirect societal and productivity costs

2. Avoiding hypoglycemia: a key to success for glucose-lowering therapy in type 2 diabetes

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Barriers and solutions for the management of severe hypoglycaemia in people with diabetes in Spain: A Delphi survey;Primary Care Diabetes;2023-12

2. A European Cost–Utility Analysis of the MiniMed™ 780G Advanced Hybrid Closed-Loop System Versus Intermittently Scanned Continuous Glucose Monitoring with Multiple Daily Insulin Injections in People Living with Type 1 Diabetes;Diabetes Technology & Therapeutics;2023-12-01

3. Epidemiological, Social and Economic Burden of Severe Hypoglycaemia in Patients with Diabetes Mellitus in Portugal: A Structured Literature Review;Diabetes Therapy;2023-01-21

4. Impacto en hipoglucemia grave y costes sanitarios del uso del sistema FreeStyle en población pediátrica con diabetes mellitus tipo 1;Endocrinología, Diabetes y Nutrición;2022-10

5. Impact on variables of severe hypoglycaemia and healthcare costs of the use of the FreeStyle system in paediatric population with type 1 diabetes mellitus;Endocrinología, Diabetes y Nutrición (English ed.);2022-10